Panacea Laboratories, a division of Panacea Pharmaceuticals, Inc.
Serum and tissue tests are being developed to aid in the diagnosis, surveillance and monitoring of several malignancies including liver, ovarian and other cancers. Panacea Laboratories developed BC Detectsm, CC Detectsm, LC Detectsm, PC Detect® and TK Sense®, and has determined their analytical performance characteristics. Panacea Laboratories is regulated under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high-complexity testing. BC Detectsm, CC Detectsm, LC Detectsm, PC Detect® and TK Sense® are intended to be used for clinical purposes.
|
|
Available Diagnostic Test:
BC Detectsm: breast cancer.
CC Detectsm: colorectal cancer.
LC Detectsm: lung cancer.
PC Detect®: prostate cancer.
TK Sense® A RT-PCR (gene expression) test that predicts the response of patients with Chronic Myelogenous Leukemia (CML) to imatinib (Gleevec®).
|
